US Stock MarketDetailed Quotes
PYXS Pyxis Oncology
- 2.100
- -1.720-45.03%
Close Nov 21 16:00 ET
- 2.070
- -0.030-1.43%
Post 17:12 ET
124.88MMarket Cap-1981P/E (TTM)
2.390High1.900Low15.10MVolume2.170Open3.820Pre Close31.52MTurnover38.40%Turnover RatioLossP/E (Static)59.47MShares6.85052wk High0.81P/B82.59MFloat Cap1.48052wk Low--Dividend TTM39.33MShs Float19.000Historical High--Div YieldTTM12.83%Amplitude1.100Historical Low2.086Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Pyxis Oncology Stock Forum
This is the PYXS entire press release from its website
pyxisoncology.c...
Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
PDF Version
— PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and front-line combo ther...
•
PYX-201 achieved a confirmed 50% ORR by RECIST 1.1 including one Complete Response and 100% Disease Control Rate in six heavily pretreated HNSCC patients, supporting differentiated mono and front-line combo therapy expansion trials to begin dosing 1Q25
•
Overall, 26% ORR across six Solid Tumor Types of Interest (n=31) with Dose Dependent Responses Observed, Sup...
No comment yet